Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Consolidated Net Income/Loss data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Consolidated Net Income/Loss |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$11.17B |
|
$3.15B |
|
$4.55B |
|
$15.72B |
|
$1.85B |
|
-- |
|
$172.11M |
|
$2.02B |
|
$13.70B |
|
$13.47B |
|
$13.70B |
|
3.29B |
|
| Cash Flow Statement Financials | |
$1.28B |
|
$-920.94M |
|
$-675.12M |
|
$3.73B |
|
$3.43B |
|
$-297.49M |
|
-- |
|
$-647.54M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|